Latest Breaking News On - Oxana beskrovnaya - Page 1 : comparemela.com

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesStacy nartkerAmy reillyOxana beskrovnayaExchange commissionSociety international research congressDyne therapeutics incFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Dyne Therapeutics Presents New Preclinical Data for its

Dyne Therapeutics Presents New Preclinical Data for its
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAmy reillyStacy nartkerOxana beskrovnayaExchange commissionSociety international research congressDyne therapeutics incFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAmy reillyOxana beskrovnayaStacy nartkerFacioscapulohumeral muscular dystrophy program duringExchange commissionSociety international research congressDyne therapeutics incTherapeutics presents new preclinical dataInternational researchFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Frazier Life Sciences Management L P Invests $15 76 Million in Dyne Therapeutics, Inc (NASDAQ:DYN)

Frazier Life Sciences Management L.P. bought a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,184,840 shares of the company’s stock, valued at approximately $15,758,000. Frazier Life Sciences Management L.P. owned 1.93% of Dyne Therapeutics at […]

United statesOxana beskrovnayaStifel nicolausDyne therapeutics incChina universal asset management coMorgan stanleySg americas securitiesFrazier life sciences managementJefferies financial groupCorton capital incPrincipal financial group incProfund advisorsDyne therapeuticsFree reportUniversal asset managementFinancial group

Dyne Therapeutics, Inc (NASDAQ:DYN) Receives Consensus Recommendation of Buy from Brokerages

Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have received a consensus rating of “Buy” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price […]

United statesOxana beskrovnayaPiper sandlerJoshuat brummZurcher kantonalbank zurich cantonalbankStifel nicolausMorgan stanleyDyne therapeutics company profileAmeritas investment partners incChina universal asset management coDyne therapeutics incEntrypoint capitalWetzel investment advisors incDyne therapeuticsGet free reportMarketbeat ratings